Clinical impact of time to positivity for Candida species on mortality in patients with candidaemia
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Si-Hyun | - |
dc.contributor.author | Yoon, Young Kyung | - |
dc.contributor.author | Kim, Min Ja | - |
dc.contributor.author | Sohn, Jang Wook | - |
dc.date.accessioned | 2021-09-05T18:31:04Z | - |
dc.date.available | 2021-09-05T18:31:04Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2013-12 | - |
dc.identifier.issn | 0305-7453 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/101501 | - |
dc.description.abstract | Objectives: The time to positivity (TIP) of blood cultures is associated with the microbial load in the blood and prognosis in patients with bloodstream infections caused by various bacterial species. However, relevant information about the TIP for Candida species in candidaemia is limited. We investigated the clinical impact of the TIP on mortality in patients with candidaemia. Methods: All consecutive patients >= 18 years of age with candidaemia between January 2006 and July 2012 were included. The demographics, clinical and microbiological characteristics, antifungal treatment and outcomes of the patients were collected retrospectively. Results:A total of 152 patients were identified. The overall mortality rate at 6 weeks was 53%. The median TIP for Candida isolates was 27 h (IQR 19-37 h). A TIP of <= 24 h was significantly related to a higher mortality rate (P=0.021). In a multivariate Cox regression analysis, the Charlson comorbidity index value [adjusted hazard ratio (HR) 1.15, 95% CI 1.02-1.29, P=0.018], sequential organ failure assessment score (adjusted HR 1.23, 95% CI 1.13-1.34, P<0.001), TIP <= 24 h (adjusted HR 2.74, 95% CI 1.51-4.97, P=0.001), timing of appropriate antifungal therapy >72 h (adjusted HR 2.38,95% CI 1.26-4.51, P=0.008) and persistent candidaemia (adjusted HR 2,50, 95% CI 1.33-4.72, P=0.005) were independently associated with the 6 week mortality rate. Conclusions: A short TIP (<= 24 h) for Candida species was independently associated with increased mortality in patients with candidaemia. Additional studies on the relevance of the TIP to clinical outcome in patients with candidaemia are needed. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | OXFORD UNIV PRESS | - |
dc.subject | BLOOD-STREAM INFECTION | - |
dc.subject | ESCHERICHIA-COLI BACTEREMIA | - |
dc.subject | ANTIFUNGAL THERAPY | - |
dc.subject | PRACTICE GUIDELINES | - |
dc.subject | CULTURE POSITIVITY | - |
dc.subject | DISEASES SOCIETY | - |
dc.subject | ORGAN FAILURE | - |
dc.subject | 2009 UPDATE | - |
dc.subject | SEPSIS | - |
dc.subject | SUSCEPTIBILITY | - |
dc.title | Clinical impact of time to positivity for Candida species on mortality in patients with candidaemia | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yoon, Young Kyung | - |
dc.contributor.affiliatedAuthor | Kim, Min Ja | - |
dc.contributor.affiliatedAuthor | Sohn, Jang Wook | - |
dc.identifier.doi | 10.1093/jac/dkt256 | - |
dc.identifier.scopusid | 2-s2.0-84887534679 | - |
dc.identifier.wosid | 000326980000027 | - |
dc.identifier.bibliographicCitation | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, v.68, no.12, pp.2890 - 2897 | - |
dc.relation.isPartOf | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | - |
dc.citation.title | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | - |
dc.citation.volume | 68 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 2890 | - |
dc.citation.endPage | 2897 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Infectious Diseases | - |
dc.relation.journalResearchArea | Microbiology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
dc.relation.journalWebOfScienceCategory | Microbiology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | BLOOD-STREAM INFECTION | - |
dc.subject.keywordPlus | ESCHERICHIA-COLI BACTEREMIA | - |
dc.subject.keywordPlus | ANTIFUNGAL THERAPY | - |
dc.subject.keywordPlus | PRACTICE GUIDELINES | - |
dc.subject.keywordPlus | CULTURE POSITIVITY | - |
dc.subject.keywordPlus | DISEASES SOCIETY | - |
dc.subject.keywordPlus | ORGAN FAILURE | - |
dc.subject.keywordPlus | 2009 UPDATE | - |
dc.subject.keywordPlus | SEPSIS | - |
dc.subject.keywordPlus | SUSCEPTIBILITY | - |
dc.subject.keywordAuthor | bloodstream infections | - |
dc.subject.keywordAuthor | blood cultures | - |
dc.subject.keywordAuthor | antifungal therapy | - |
dc.subject.keywordAuthor | outcomes | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.